Clinical Trial

Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
\<Purpose of the Research\> * Primary Establishing an Asian consortium to establish a database of pediatric CNS tumors in the prospective manner The target disease of this research focuses on pediatric tumors, and initially the registration of patients with CNS GCT will begin first. * Secondary Developing clinical protocols for pediatric CNS tumors based in Asia \<Duration of Research Participation\> Registration period for research subjects: 2022-08-01 - 2027-12-31 Duration of medical records to be utilized: to 2030-12-31 Total projected duration of research: IRB approved to 2032-12-31 Interim assessment of data quality and integrity: 6 Mo after Data collection Evaluation for the Adaptation of Protocols: 1 and 2 years after the initiation of the study Analysis of Quality of Life and other questionnaires: 3 and 5 years Interim Analysis of all data: 5 years (2027) Final analysis of treatment outcome: 2032
Trial Details
NCT Number NCT05982691
Lead Sponsor National Cancer Center, Korea
Conditions CNS Germinoma, CNS Tumor, Asian Consortium
Enrollment 400 participants
Start Date 2022-08-05
Primary Completion 2028-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-08-08